MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


AIM WINNERS & LOSERS: Allergy Therapeutics plunges as results delayed

ALN

The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Strategic Minerals PLC, up 7.6% at 0.27 pence, 12-month range 0.20p - 0.45p. Says its subsidiary, Leigh Creek Copper Mine Pty Ltd, has lodged an application for a new Program for Environmental Protection & Rehabilitation with South Australia’s Department of Energy & Mining. The lodgement of the PEPR is related to planned mining at Paltridge North, within Leigh Creek, and constitutes part of the expected 2023 re-opening of operations at Mountain of Light - also on the site - subject to funding.

----------

Tekcapital PLC, up 1.4% at 18.25 pence, 12-month range 15.65p - 37.80p. Investee Innovative Eyewear Inc licences outdoor brand Eddie Bauer for its smart eyewear through an agreement with Authentic Brands Group LLC. The company describes the contract as a ‘multi-year, global licensing agreement’, without providing financial details. The Eddie Bauer smart eyewear collection is expected to launch in 2023.

----------

AIM - LOSERS

----------

Allergy Therapeutics PLC, down 52% at 5.45 pence, 12-month range 4.00p - 33.50p. Says its shares will be suspended next week, due to delays in completing the audit of its annual results. Back in September, the company announced its unaudited preliminary results for the financial year that ended June 30. It sunk to a pretax loss of £12.7 million from a profit of £3.7 million the year prior. Revenue dropped to £72.8 million from £84.3 million. ‘It is not aware of any material change that will be required to be made to the results, and it is actively working to finalise the audit and publication of its annual report and accounts,’ the commercial biotechnology firm says.

----------

Kazera Global PLC, down 15% at 0.90 pence, 12-month range 0.70p - 1.64p. Says its annual results will not be published before the end of the year, due to delays at its wholly-owned subsidiary African Tantalum (Proprietary) Ltd. The diamond and rare earths explorer now expects to release its results for the financial year that ended June 30 during February. As a result, its shares will be suspended from trading on AIM in London from Tuesday next week, the first trading day of 2023. Kazera expects a loss of £1.1 million on income of £107,000.

----------

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2022 Alliance News Ltd. All Rights Reserved.